Market-Moving News for December 28th

CINGULATE INC. +3.85%
SEALSQ Corp - Ordinary Shares -3.93%
Microbot Medical Inc -8.25%

CINGULATE INC.

CING

0.81

+3.85%

SEALSQ Corp - Ordinary Shares

LAES

1.10

-3.93%

Microbot Medical Inc

MBOT

0.94

-8.25%

CING: 460% | Cingulate Said We Received Guidance From The FDA Regarding Its Clinical Program For CTX-1301 its Lead Investigational Product Candidate For The Treatment Of ADHD. Based On This Guidance, We Expect To Submit The NA For CTX-1301 In H1 2025

LAES: 222% | SEALSQ Disclosed That Its Post-quantum Semiconductor Technology Based On Cryptographic Algorithms, Is Specifically Designed To Withstand Attacks From And Secure Cryptocurrency Transactions Against The Looming Threat Of Quantum Computing

MBOT: 67% | Microbot Medical Disclosed The Successful Completion Of Its GLP Pivotal Pre-clinical Study, Done Under The Guidelines Of FDA-required Levels Of Planning, Controlling, Monitoring, And Reporting, Using A Porcine Model

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via